Suppr超能文献

血色病或高血铁蛋白症患者的红细胞和纤维蛋白网络的深刻形态变化,以及铁螯合剂和其他药物的正常化。

Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents.

机构信息

Department of Physiology, University of Pretoria, Arcadia, South Africa.

Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States of America.

出版信息

PLoS One. 2014 Jan 9;9(1):e85271. doi: 10.1371/journal.pone.0085271. eCollection 2014.

Abstract

It is well-known that individuals with increased iron levels are more prone to thrombotic diseases, mainly due to the presence of unliganded iron, and thereby the increased production of hydroxyl radicals. It is also known that erythrocytes (RBCs) may play an important role during thrombotic events. Therefore the purpose of the current study was to assess whether RBCs had an altered morphology in individuals with hereditary hemochromatosis (HH), as well as some who displayed hyperferritinemia (HF). Using scanning electron microscopy, we also assessed means by which the RBC and fibrin morphology might be normalized. An important objective was to test the hypothesis that the altered RBC morphology was due to the presence of excess unliganded iron by removing it through chelation. Very striking differences were observed, in that the erythrocytes from HH and HF individuals were distorted and had a much greater axial ratio compared to that accompanying the discoid appearance seen in the normal samples. The response to thrombin, and the appearance of a platelet-rich plasma smear, were also markedly different. These differences could largely be reversed by the iron chelator desferal and to some degree by the iron chelator clioquinol, or by the free radical trapping agents salicylate or selenite (that may themselves also be iron chelators). These findings are consistent with the view that the aberrant morphology of the HH and HF erythrocytes is caused, at least in part, by unliganded ('free') iron, whether derived directly via raised ferritin levels or otherwise, and that lowering it or affecting the consequences of its action may be of therapeutic benefit. The findings also bear on the question of the extent to which accepting blood donations from HH individuals may be desirable or otherwise.

摘要

众所周知,铁含量升高的个体更容易发生血栓性疾病,主要是由于未配位的铁的存在,从而增加了羟基自由基的产生。也已知红细胞(RBC)在血栓形成事件中可能发挥重要作用。因此,本研究的目的是评估遗传性血色素沉着症(HH)患者以及一些表现为高血铁蛋白血症(HF)的个体中 RBC 是否具有改变的形态,以及评估通过螯合作用使 RBC 和纤维蛋白形态正常化的方法。一个重要的目标是测试通过螯合去除多余的未配位铁导致 RBC 形态改变的假设。通过扫描电子显微镜观察到非常明显的差异,即 HH 和 HF 个体的红细胞变形,并且与正常样本中所见的圆盘状外观相比,轴向比大得多。对凝血酶的反应以及富含血小板的血浆涂片的外观也明显不同。这些差异可以通过铁螯合剂去铁胺在很大程度上逆转,并且在一定程度上可以通过铁螯合剂氯喹啉或自由基捕获剂水杨酸或亚硒酸盐(其本身也可能是铁螯合剂)逆转。这些发现与以下观点一致,即 HH 和 HF 红细胞的异常形态至少部分是由未配位的(“游离”)铁引起的,无论是直接通过升高的铁蛋白水平还是其他方式引起的,并且降低其水平或影响其作用的后果可能具有治疗益处。这些发现还涉及到从 HH 个体接受献血的程度是否可取或其他方面的问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afc1/3887013/de12da6115ea/pone.0085271.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验